| Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain K Schmierer, F Scaravilli, DR Altmann, GJ Barker, DH Miller Annals of neurology 56 (3), 407-415, 2004 | 915 | 2004 |
| Association between pathological and MRI findings in multiple sclerosis M Filippi, W Brück, D Chard, F Fazekas, JJG Geurts, C Enzinger, ... The Lancet Neurology 18 (2), 198-210, 2019 | 726 | 2019 |
| Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study L Kappos, R Gold, DH Miller, DG MacManus, E Havrdova, V Limmroth, ... The Lancet 372 (9648), 1463-1472, 2008 | 644 | 2008 |
| Diffusion tensor imaging of post mortem multiple sclerosis brain K Schmierer, CAM Wheeler-Kingshott, PA Boulby, F Scaravilli, ... Neuroimage 35 (2), 467-477, 2007 | 473 | 2007 |
| Is it time to target no evident disease activity (NEDA) in multiple sclerosis? G Giovannoni, B Turner, S Gnanapavan, C Offiah, K Schmierer, M Marta Multiple sclerosis and related disorders 4 (4), 329-333, 2015 | 413 | 2015 |
| No cerebrocervical venous congestion in patients with multiple sclerosis F Doepp, F Paul, JM Valdueza, K Schmierer, SJ Schreiber Annals of neurology 68 (2), 173-183, 2010 | 381 | 2010 |
| High field MRI correlates of myelin content and axonal density in multiple sclerosis: a post-mortem study of the spinal cord JP Mottershead, K Schmierer, M Clemence, JS Thornton, F Scaravilli, ... Journal of neurology 250, 1293-1301, 2003 | 347 | 2003 |
| Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation K Schmierer, CAM Wheeler‐Kingshott, DJ Tozer, PA Boulby, HG Parkes, ... Magnetic Resonance in Medicine: An Official Journal of the International …, 2008 | 332 | 2008 |
| Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain K Schmierer, DJ Tozer, F Scaravilli, DR Altmann, GJ Barker, PS Tofts, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2007 | 326 | 2007 |
| A review of structural magnetic resonance neuroimaging M Symms, HR Jäger, K Schmierer, TA Yousry Journal of Neurology, Neurosurgery & Psychiatry 75 (9), 1235-1244, 2004 | 314 | 2004 |
| Memory B cells are major targets for effective immunotherapy in relapsing multiple sclerosis D Baker, M Marta, G Pryce, G Giovannoni, K Schmierer EBioMedicine 16, 41-50, 2017 | 286 | 2017 |
| Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis N Scolding, D Barnes, S Cader, J Chataway, A Chaudhuri, A Coles, ... Practical neurology 15 (4), 273-279, 2015 | 272 | 2015 |
| Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI RA Farrell, D Antony, GR Wall, DA Clark, L Fisniku, J Swanton, Z Khaleeli, ... Neurology 73 (1), 32-38, 2009 | 266 | 2009 |
| Interpreting lymphocyte reconstitution data from the pivotal phase 3 trials of alemtuzumab D Baker, SS Herrod, C Alvarez-Gonzalez, G Giovannoni, K Schmierer JAMA neurology 74 (8), 961-969, 2017 | 240 | 2017 |
| Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial R Raftopoulos, SJ Hickman, A Toosy, B Sharrack, S Mallik, D Paling, ... The Lancet Neurology 15 (3), 259-269, 2016 | 215 | 2016 |
| COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases D Baker, CAK Roberts, G Pryce, AS Kang, M Marta, S Reyes, K Schmierer, ... Clinical & Experimental Immunology 202 (2), 149-161, 2020 | 207 | 2020 |
| High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis K Schmierer, HG Parkes, PW So, SF An, S Brandner, RJ Ordidge, ... Brain 133 (3), 858-867, 2010 | 199 | 2010 |
| Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis C Dobson-Stone, A Danek, L Rampoldi, RJ Hardie, RM Chalmers, ... European Journal of Human Genetics 10 (11), 773-781, 2002 | 176 | 2002 |
| GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study AD Goodman, H Rossman, A Bar-Or, A Miller, DH Miller, K Schmierer, ... Neurology 72 (9), 806-812, 2009 | 167 | 2009 |
| COVID‐19 vaccine response in people with multiple sclerosis EC Tallantyre, N Vickaryous, V Anderson, AN Asardag, D Baker, ... Annals of neurology 91 (1), 89-100, 2022 | 165 | 2022 |
Gareth J BarkerProfessor of Magnetic Resonance Physics, King's College LondonZweryfikowany adres z kcl.ac.uk